Minita G Holloway
Pharmacology · 2009
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Pharmacology — 5 citations into it
Whom Minita G Holloway trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Minita G Holloway's perspective
Ordered by how strongly the researchers Minita G Holloway trusts endorse each paper. Same corpus, a different order for every researcher.
- FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. (Cell)
- Tissue-specific expression and regulation of sexually dimorphic genes in mice. (Genome Research)
- Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis (Molecular and Cellular Biology)
- Sex Differences in Pharmacokinetics and Pharmacodynamics (Clinical Pharmacokinetics)
- Circadian rhythms: mechanisms and therapeutic implications. (Annual Review of Pharmacology and Toxicology)
- Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. (Toxicology in Vitro)
- Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. (Pharmacology and Therapeutics)
- Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity (The Pharmacogenomics Journal)
- Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response (Molecular Psychiatry)
- Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism (Clinical Pharmacokinetics)
Their papers
- Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes (2009) — 747 citations